IL6 and type 2 diabetes mellitus: There is reduced skeletal muscle IL-6 receptor expression in obesity and abnormal STAT3/suppressor of cytokine signaling 3 (SOCS3) signaling, and attenuated IL-6 induced AMPKα2 activation with T2D (Scheele et al., 2012).